Trial Profile

A clinical Pharmacology PK study of Synthetic CBD Analogue to determine New Formulation of CBD for Enhanced Oral Uptake

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 11 Aug 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Synthetic CBD therapeutic-180 Life Sciences (Primary)
Indications Inflammation; Pain
Focus Pharmacokinetics

Most Recent Events

08 Aug 2023 According to a 180 Life Sciences media release, this PK study will be performed at Hadassah Hospital executed by an experienced team under the supervision of Prof. Davidson and Prof. Domb, in collaboration with 180 Life Sciences.
08 Aug 2023 According to a 180 Life Sciences media release, company announces an agreement for a Clinical Pharmacology Study assessing new formulation of CBD for enhanced oral uptake.
03 Aug 2021 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com